Wu Yong, Zhang Tian-Ying, Fang Lin-Lin, Chen Zi-Xuan, Song Liu-Wei, Cao Jia-Li, Yang Lin, Yuan Quan, Xia Ning-Shao
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China.
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China; School of Life Science, Xiamen University, Xiamen 361102, China.
J Virol Methods. 2016 Aug;234:96-100. doi: 10.1016/j.jviromet.2016.04.010. Epub 2016 Apr 22.
The stable HBV-replicating cell lines, which carry replication-competent HBV genome stably integrated into the genome of host cell, are widely used to evaluate the effects of antiviral agents. However, current methods to generate HBV-replicating cell lines, which are mostly dependent on random integration of foreign DNA via plasmid transfection, are less-efficient and time-consuming. To address this issue, we constructed an all-in-one Sleeping Beauty transposon system (denoted pTSMP-HBV vector) for robust generation of stable cell lines carrying replication-competent HBV genome of different genotype. This vector contains a Sleeping Beauty transposon containing HBV 1.3-copy genome with an expression cassette of the SV40 promoter driving red fluorescent protein (mCherry) and self-cleaving P2A peptide linked puromycin resistance gene (PuroR). In addition, a PGK promoter-driven SB100X hyperactive transposase cassette is placed in the outside of the transposon in the same plasmid.The HBV-replicating stable cells could be obtained from pTSMP-HBV transfected HepG2 cells by red fluorescence-activated cell sorting and puromycin resistant cell selection within 4-week. Using this system, we successfully constructed four cell lines carrying replication-competent HBV genome of genotypes A-D. The replication and viral protein expression profiles of these cells were systematically characterized. In conclusion, our study provides a high-efficiency strategy to generate HBV-replicating stable cell lines, which may facilitate HBV-related virological study.
稳定的乙肝病毒(HBV)复制细胞系,其携带稳定整合到宿主细胞基因组中的具有复制能力的HBV基因组,被广泛用于评估抗病毒药物的效果。然而,目前生成HBV复制细胞系的方法大多依赖于通过质粒转染随机整合外源DNA,效率较低且耗时。为了解决这个问题,我们构建了一个一体化的睡美人转座子系统(称为pTSMP-HBV载体),用于高效生成携带不同基因型具有复制能力的HBV基因组的稳定细胞系。该载体包含一个睡美人转座子,其中含有HBV 1.3拷贝基因组,带有由SV40启动子驱动红色荧光蛋白(mCherry)的表达盒以及与嘌呤霉素抗性基因(PuroR)相连的自切割P2A肽。此外,一个由PGK启动子驱动的SB100X超活性转座酶盒位于同一质粒中转座子的外部。通过红色荧光激活细胞分选和嘌呤霉素抗性细胞筛选,可在4周内从pTSMP-HBV转染的HepG2细胞中获得HBV复制稳定细胞。利用该系统,我们成功构建了四个携带A - D基因型具有复制能力的HBV基因组的细胞系。对这些细胞的复制和病毒蛋白表达谱进行了系统表征。总之,我们的研究提供了一种高效策略来生成HBV复制稳定细胞系,这可能有助于HBV相关的病毒学研究。